昭衍新药：周志文已减持1497.90万股

Core Viewpoint - The company announced that one of its actual controllers, Zhou Zhiwen, reduced his holdings in the company's A-shares by a total of 14,979,000 shares, which represents approximately 1.99894% of the company's current total share capital. The reduction plan has been terminated ahead of schedule [1]. Summary by Relevant Sections - Share Reduction Details - Zhou Zhiwen executed the share reduction from January 22 to January 28, 2026, through centralized bidding and block trading methods [1]. - The total number of shares reduced was 14,979,000 [1]. - Impact on Company Capital - The reduction accounts for nearly 2% of the company's total share capital, indicating a significant change in ownership structure [1].